Effective November 6, 2022, Alex Wylie resigned as Chief Financial Officer of Instadose Pharma Corp. and as Chief Financial Officer of its wholly owned Canadian subsidiary (“Instadose Canada”). Mr. Wylie will not hold any officer or director positions at the company or Instadose Canada following his resignation.